.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Deloitte
Novartis
US Army
Queensland Health
Medtronic
Express Scripts
Daiichi Sankyo
US Department of Justice
Citi

Generated: June 22, 2017

DrugPatentWatch Database Preview

CLORPRES Drug Profile

« Back to Dashboard

Which patents cover Clorpres, and when can generic versions of Clorpres launch?

Clorpres is a drug marketed by Mylan and is included in one NDA.

The generic ingredient in CLORPRES is chlorthalidone; clonidine hydrochloride. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorthalidone; clonidine hydrochloride profile page.

Summary for Tradename: CLORPRES

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list34
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CLORPRES at DailyMed

Pharmacology for Tradename: CLORPRES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
CLORPRES
chlorthalidone; clonidine hydrochloride
TABLET;ORAL071325-003Feb 9, 1987RXNoNo► Subscribe► Subscribe
Mylan
CLORPRES
chlorthalidone; clonidine hydrochloride
TABLET;ORAL071325-002Feb 9, 1987RXNoNo► Subscribe► Subscribe
Mylan
CLORPRES
chlorthalidone; clonidine hydrochloride
TABLET;ORAL071325-001Feb 9, 1987RXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Healthtrust
QuintilesIMS
US Army
Cantor Fitzgerald
Covington
Novartis
McKinsey
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot